Search Results

• • 2,365 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Medicaid enrollment at early stage of disease: the breast and cervical cancer prevention and treatment act in Georgia

  Authors:Li-Nien Chien, E. Kathleen Adams, and Zhou YangFrom:Inquiry: The Journal of Health Care Organization, Provision, and Financing (Vol. 48, Issue 3) Peer-Reviewed

  Fall 20115,878 words Report 1530LThis study linked data from the Georgia Comprehensive Cancer Registry to Medicaid enrollment and claims to test whether the Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA), which provided a new and...

• Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: clarity needed

  Authors:Swaroop Revannasiddaiah, Madhup Rastogi, Manoj Gupta, and Rajeev SeamFrom:Indian Journal of Medical and Paediatric Oncology (Vol. 34, Issue 1) Peer-Reviewed

  January-March 2013528 words Letter to the editor 1390LByline: Swaroop. Revannasiddaiah, Madhup. Rastogi, Manoj. Gupta, Rajeev. Seam Sir, Having read the article titled, "Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized...

• Evaluation of socio-demographic factors for non-compliance to treatment in locally advanced cases of cancer cervix in a rural medical college hospital in India

  Authors:Samrat Dutta, Nandita Biswas, and Goutam MuhkherjeeFrom:Indian Journal of Palliative Care (Vol. 19, Issue 3) Peer-Reviewed

  September-December 20134,060 words Report 1660LByline: Samrat. Dutta, Nandita. Biswas, Goutam. Muhkherjee Introduction: Carcinoma cervix is a leading cause of cancer in India. However, majority of the patients face a problem of not being able to complete the...

• A tumor of the uterine cervix with a complex histology in a Peutz-Jeghers syndrome patient with genomic deletion of the STK11 exon 1 region

  Authors:Yusuke Kobayashi, Kenta Masuda, Tokuhiro Kimura, Hiroyuki Nomura, Akira Hirasawa, Kouji Banno, et al.From:Future Oncology (Vol. 10, Issue 2) Peer-Reviewed

  Feb. 20142,751 words Report 1330LAuthor(s): Yusuke Kobayashi [*] 4 , Kenta Masuda 1 , Tokuhiro Kimura 2 , Hiroyuki Nomura 1 , Akira Hirasawa 1 , Kouji Banno 1 , Nobuyuki Susumu 1 , Kokichi Sugano 3 , Daisuke Aoki 1 KEYWORDS * lobular...

• Imaging findings after radiotherapy to the pelvis

  Authors:Pavan Lachi, Sujatha Patnaik, K. Amit, and K. V J R. NaiduFrom:Journal of Cancer Research and Therapeutics (Vol. 11, Issue 3) Peer-Reviewed

  July-September 20151,442 words Report 1480LByline: Pavan. Lachi, Sujatha. Patnaik, K. Amit, K. V. J. R.. Naidu Carcinoma cervix is the second most common malignancy in women worldwide, and it remains a leading cause of cancer-related death in women in...

• Monitoring the coverage and impact of human papillomavirus vaccine--report of WHO meeting, November 2009/Surveillance de la couverture et des effets du vaccin antipapillomavirus humain--rapport d'une reunion de l'OMS, novembre 2009

  From:Weekly Epidemiological Record (Vol. 85, Issue 25)

  June 18, 20106,634 words Report 1850LWHO recommends that routine vaccination against human papillomavirus (HPV) be included in national immunization programmes provided that (i) the prevention of cervical cancer or other HPV-related diseases constitutes a...

• Prevalence of human papillomavirus infection in women attending a gynecology/oncology clinic in Qatar

  Authors:Asma AJ Al-Thani, Aesha I Abu-Rub, Afaf Al-Ansari, Mandy Abushama, Moza Al-Khanji, and Sabah Al-LawatiFrom:Future Virology (Vol. 5, Issue 4)

  July 20103,824 words Clinical report Author(s): Asma AJ Al-Thani [[dagger]] 4 , Aesha I Abu-Rub 1 , Afaf Al-Ansari 2 , Mandy Abushama 2 , Moza Al-Khanji 1 , Sabah Al-Lawati 3 Keywords: Keywords * cervical cancer; HPV; HPV; genotypes; Qatar...

• When and how often should PET scans be performed in the management of cervical cancer?

  Authors:Chyong-Huey Lai and Tzu-Chen YenFrom:Expert Review of Anticancer Therapy (Vol. 10, Issue 7) Peer-Reviewed

  July 20102,783 words Editorial 1490LAuthor(s): Chyong-Huey Lai [[dagger]â ] 1 , Tzu-Chen Yen 2 Cervical cancer is the second most common cancer among women worldwide [1] . The International Federation of Gynecology and Obstetrics (FIGO) stage and lymph...

• The mechanisms behind human papillomavirus-associated cancer: the role of PDZ recognition in malignant progression

  Authors:Kazunori Nagasaka, Shunsuke Nakagawa, Tetsu Yano, Yuji Taketani, and Lawrence BanksFrom:Future Virology (Vol. 6, Issue 6)

  June 20112,402 words Editorial 1420LAuthor(s): Kazunori Nagasaka 1 2 , Shunsuke Nakagawa 2 , Tetsu Yano 2 , Yuji Taketani 2 , Lawrence Banks [[dagger]â ] 3 Keywords *⪠cancer; cell polarity; E6; HPV; PDZ; PKA Cervical cancer is the second...

• Perspectives for the development of human papillomavirus vaccines and immunotherapy

  Authors:Luis G Bermudez-Humaran and Philippe LangellaFrom:Expert Review of Vaccines (Vol. 9, Issue 1) Peer-Reviewed

  Jan. 20107,609 words Report 1530LAuthor(s): Luis G Bermúdez-Humarán [[dagger]] 1 , Philippe Langella 2 Keywords : bacterial vectors; cervical cancer; human papillomavirus; immunotherapy; mucosal vaccines Cervical cancer (CxCa) remains a...

• Laparoscopic debulking of lymph nodes in cervical cancer

  Author:Dion SmythFrom:Cancer Nursing Practice (Vol. 8, Issue 5) Peer-Reviewed

  June 2009227 words Brief article, Repor... 1320LThe presence of lymph-node metastases is the most important prognostic factor for survival in women with cervical cancer, with progression to pelvic and para-aortic nodes predicting particularly negative prospects....

• Cervical cancer vaccine proves highly effective in recently published landmark study

  From:Oncology (Vol. 23, Issue 10) Peer-Reviewed

  Sept. 2009379 words Brief article, Clini... 1630LThe final analysis of the largest efficacy trial of a cervical cancer vaccine was published July 25, 2009, in The Lancet. The study, involving 18,644 women, confirmed GlaxoSmithKline's Cervarix is highly effective at...

• Test group biases and ethical concerns mar New England Journal of Medicine articles promoting HPV screening for cervical cancer in rural India

  Authors:R. Austin and Chengquan ZhaoFrom:CytoJournal (Vol. 6) Peer-Reviewed

  January-December 20092,331 words Viewpoint essay Byline: R. Austin, Chengquan. Zhao The study conclusions, released from prepublication embargo by the New England Journal of Medicine (NEJM ) at 5:00 PM on April 1, 2009, were dramatic. "In a low resource setting, a...

• Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts

  Authors:Vikrant V Sahasrabuddhe, Patricia Luhn, and Nicolas WentzensenFrom:Future Microbiology (Vol. 6, Issue 9)

  Sept. 201111,234 words Article 1590LAuthor(s): Vikrant V Sahasrabuddhe 1 , Patricia Luhn 1 , Nicolas Wentzensen [[dagger]] 2 Keywords * accuracy; biomarkers; cervical cancer; HPV; prevention; risk prediction; screening Cervical cancer:...

• Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium

  Authors:Lieven Annemans, Vanessa Remy, James Oyee, and Nathalie LargeronFrom:PharmacoEconomics (Vol. 27, Issue 3) Peer-Reviewed

  Mar. 20096,899 words Article Background: The introduction of a quadrivalent human papillomavirus (HPV; types 6, 11, 16, 18) vaccine is expected to significantly reduce the burden of cervical cancer, cervical intraepithelial neoplasia (CIN), genital...

• Human papillomavirus vaccines WHO position paper/Vaccins anti-papillomavirus humain Note d'information de l'OMS

  From:Weekly Epidemiological Record (Vol. 84, Issue 15)

  Apr. 10, 200913,035 words Report 1880LIn accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and vaccine combinations against diseases that have an...

• A sexual health prevention priority

  Authors:Stephen Peckham and Alison HannFrom:Bulletin of the World Health Organization (Vol. 86, Issue 6) Peer-Reviewed

  June 2008972 words Clinical report 1720LWittet and Tsu are right to point to the link between cervical cancer deaths and achieving the MDGs and the inequity in the burden of cervical cancer between developed and developing countries. Any programme that...

• Deprivation doubles cervical cancer

  From:Practice Nurse (Vol. 36, Issue 10)

  Dec. 12, 2008226 words Brief article 1480LWomen living in the most deprived are as of England are nearly twice as likely to be diagnosed with cervical cancer than their affluent counterparts, new research has revealed. The researchers believe that the...

• Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix[TM]]: profile report

  Authors:Susan J. Keam and Diane M. HarperFrom:BioDrugs (Vol. 22, Issue 3) Peer-Reviewed

  May-June 20082,953 words Article 3250LWorldwide, cervical cancer is the second most common cancer in women after breast cancer. [2,3] Current statistical analyses estimate that in 2002, 493 000 new cases of invasive cervical cancer were diagnosed and that...

• Long-term follow-up of a quadrivalent HPV vaccine

  Author:John S LambertFrom:Expert Review of Vaccines (Vol. 6, Issue 2) Peer-Reviewed

  Apr. 20073,334 words Article Author(s): John S Lambert 1 Keywords: cervical cancer prevention; human papillomavirus; prevention of genital warts; vaccine Human papillomavirus (HPV) vaccines have now been licensed for use and long-term...